Related references
Note: Only part of the references are listed.Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Chemoreirradiation for recurrent salivary gland malignancies
Aaron W. Pederson et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma
Tawee Tanvetyanon et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L. D. Locati et al.
ORAL ONCOLOGY (2009)
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: Implications for adjuvant therapy
Allen M. Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model
Maher N. Younes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Systemic therapy in the palliative management of advanced salivary gland cancers
Scott A. Laurie et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemoradiotherapy for adenoid cystic carcinoma - Preliminary results of an organ sparing approach
RI Haddad et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment
M. W. Muenter et al.
RADIATION ONCOLOGY (2006)
Salivary gland adenoid cystic carcinoma: A review of chemotherapy and molecular therapies
R. L. Dodd et al.
ORAL ONCOLOGY (2006)
Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques
D Schulz-Ertner et al.
CANCER (2005)
Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation
TA Gurney et al.
LARYNGOSCOPE (2005)
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: A Princess Margaret Hospital phase II consortium study
SJ Hotte et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of radiotherapy in the treatment of malignant salivary gland tumors
CHJ Terhaard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck
WM Mendenhall et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2004)
Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer
J Mizoe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Treatment of salivary gland neoplasms with fast neutron radiotherapy
JG Douglas et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin
M Vered et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2002)
Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?
PE Huber et al.
RADIOTHERAPY AND ONCOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
